Truvada for PrEP Shows To Be Less Dangerous Than Daily Aspirin

A study published in the Oxford journal of Medicine shows that Truvada, the medication used for PrEP HIV infection prevention is much safer than originally thought:

We conclude that FTC-TDF for PrEP for HIV infection favorably compares to aspirin in terms of user safety. While long-term studies are needed, providers should feel reassured about the safety of short- and medium-term PrEP for HIV infection with FTC-TDF.

Translation? Truvada, the combination tablet of Tenofovir and Emtricitabine has a better risk and side effect profile than aspirin a tablet used daily in the prevention of heart disease.

This is a good news for people who are concerned about the side effects of PrEP such as kidney issues or bone density issues.

Dr George